Radiopharmaceutical Therapy


Our experienced team of oncology specialists is helping bring to light important ideas to help maximize success of this new option for the treatment of cancer.

Ghassan El-Haddad, MD
Associate Professor, Moffitt Cancer Center and
Research Institute at the University of South Florida
Dr. El-Haddad received his MD from the Lebanese University in Beirut, Lebanon. After his internship at SUNY Upstate Medical University, he completed his residency in Nuclear Medicine as well as a fellowship in Nuclear Oncology at the Hospital of the University of Pennsylvania in Philadelphia, PA.
Read More
Suzanne Lapi, PhD
Professor, Advanced Imaging Facility, Division of Advanced
Medical Imaging Research
University of Alabama
Dr. Suzanne Lapi completed her undergraduate studies and Ph.D. at Simon Fraser University in Burnaby, BC, Canada. She went on to complete a postdoctoral appointment at UCSF working with Henry VanBrocklin, Ph.D. on the development of imaging agents for PSMA in prostate cancer before being recruited as a faculty member at Washington University in St. Louis where she ultimately stayed on as a tenured Associate Professor until 2015.
Read More
Zachary Morris, MD
Radiation Oncologist at FHN Leonard Ferguson Cancer Center
Affiliate Faculty at Loyola University Stritch School of Medicine
Founder and President of Paramount Oncology Group
Dr. Zachary Morris is an assistant professor and vice chair of the Department of Human Oncology at the University of Wisconsin School of Medicine and Public Health. He serves as program director of Bentson Translational Research Fellowship program and DEI director of the department of Human Oncology.
Read More
Jeff Norenberg, PhD
Professor Emeritus of Pharmacy and Anesthesiology & Critical Care Medicine,
former Director of Radiopharmaceutical Sciences at UNM HSC – Retired
Radiopharmaceutical Product Development Consultant, Dir NANP
Dr. Jeff Norenberg completed his post-graduate training in nuclear pharmacy and PET radiochemistry at the National Institutes of Health in Bethesda, Maryland while serving in the US Public Health Service. He is an expert in the design and development of targeted radioligands for molecular imaging and therapy.
Read More
Oliver Sartor, MD
Director Radiopharmaceutical Trials
Mayo Clinic
Professor Oliver Sartor is a medical oncologist and translational researcher with a special focus on prostate cancer over the past 33 years. He completed his fellowship in Medical Oncology in 1989 at the National Cancer Institute, Bethesda and is currently Director of Radiopharmaceutical Clinical Trials at Mayo Clinic in Rochester, Minnesota.
Read More